Related Experiment Video
Updated: Sep 16, 2025

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
Architecturally Low-Grade Pure Cylindrocarcinoma With CYLD1 Mutation
Ronan Knittel1, Shona Hendry2, Benjamin A Wood1,3
1PathWest Dermatopathology, PathWest Laboratory Medicine, J Block, QEII Medical Centre, Perth, WA, Australia.
This study details a rare case of pure cylindrocarcinoma, a malignant adnexal neoplasm. The findings highlight a unique presentation and an inactivating CYLD1 mutation, advancing understanding of this rare cancer.
Area of Science:
- Dermatopathology
- Oncology
- Genetics
Background:
- Cylindrocarcinoma is a rare malignant adnexal neoplasm.
- Diagnosis often relies on identifying a precursor benign component (cylindroma).
- The World Health Organization classifies these as malignant neoplasms arising from cylindroma.
Purpose of the Study:
- To present a unique case of pure, architecturally low-grade cylindrocarcinoma.
- To support the diagnosis with detailed morphologic and immunohistochemical features.
- To investigate the genetic basis, specifically CYLD1 mutations.
Main Methods:
- Morphological analysis of the tumor.
- Immunohistochemical staining.
- Genetic analysis for CYLD1 mutation.
Main Results:
- The case presented as a pure cylindrocarcinoma without a discernible benign precursor.
- Distinctive morphologic and immunohistochemical findings supported the diagnosis.
- An inactivating mutation in the CYLD1 gene was identified.
Conclusions:
- Pure cylindrocarcinoma, though rare, can occur without a benign component.
- Morphologic and immunohistochemical features are crucial for diagnosis.
- CYLD1 gene mutations may play a role in the pathogenesis of cylindrocarcinoma.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
10:49Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Published on: January 21, 2019
Related Concept Videos
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...